Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 229.40
-3.50 (-1.50%)
At close: Nov 6, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 101.25 billion as of November 6, 2026. It is the 9,515th most valuable company in the world and the 588th biggest in India. Its market cap has increased by 83.89% in one year.
Market Cap
101.25B
Enterprise Value
105.59B
Revenue
35.75B
Global Rank
Country Rank
#588 India
PE Ratio
48.32
ChartMarket Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 101.25B, an increase of 29,014.58%. That is a compound annual growth rate of 29.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 101.25B | 11.63% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Granules India | 198.23B |
| Caplin Point Laboratories | 181.01B |
| AstraZeneca Pharma India | 159.70B |
| Jubilant Pharmova | 148.66B |
| Procter & Gamble Health | 92.04B |
| Sanofi India | 75.61B |
| Bliss GVS Pharma | 64.16B |
| FDC Limited | 63.49B |